Codiak BioSciences, Inc. Restricted Cash, Noncurrent
Codiak BioSciences, Inc. had Restricted Cash, Noncurrent of $4.17 million as of 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:RestrictedCashNoncurrent · last filed 2022-11-03
- 2022-09-30: Restricted Cash, Noncurrent $4.17M.
- 2022-06-30: Restricted Cash, Noncurrent $4.17M.
- 2022-03-31: Restricted Cash, Noncurrent $4.17M.
- 2021-12-31: Restricted Cash, Noncurrent $4.17M.
| Period end | Restricted Cash, Noncurrent |
|---|---|
| 2022-09-30 | $4.17M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $4.17M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $4.17M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $4.17M 10-Q · filed 2022-11-03 |
| 2021-09-30 | $4.17M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $4.17M 10-Q · filed 2022-08-04 |
| 2021-03-31 | $4.17M 10-Q · filed 2022-05-05 |
| 2020-12-31 | $4.17M 10-K · filed 2022-03-10 |
| 2020-09-30 | $4.17M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $4.17M 10-Q · filed 2021-08-05 |
| 2020-03-31 | $4.17M 10-Q · filed 2021-05-06 |
| 2019-12-31 | $4.17M 10-K · filed 2021-03-17 |
| 2019-09-30 | $4.17M 10-Q · filed 2020-11-19 |